PL356884A1 - Nowe pochodne imidazolu - Google Patents

Nowe pochodne imidazolu

Info

Publication number
PL356884A1
PL356884A1 PL01356884A PL35688401A PL356884A1 PL 356884 A1 PL356884 A1 PL 356884A1 PL 01356884 A PL01356884 A PL 01356884A PL 35688401 A PL35688401 A PL 35688401A PL 356884 A1 PL356884 A1 PL 356884A1
Authority
PL
Poland
Prior art keywords
imidazole derivatives
new imidazole
formula
new
derivative
Prior art date
Application number
PL01356884A
Other languages
English (en)
Other versions
PL207281B1 (pl
Inventor
Paavo Huhtala
Arto Karjalainen
Antti Haapalinna
Jyrki Lehtimaki
Arja Karjalainen
Raimo Virtanen
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of PL356884A1 publication Critical patent/PL356884A1/pl
Publication of PL207281B1 publication Critical patent/PL207281B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL356884A 2000-01-14 2001-01-12 Pochodna imidazolu, kompozycja ją zawierająca, jej zastosowanie i sposób wytwarzania PL207281B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20000073A FI20000073A0 (fi) 2000-01-14 2000-01-14 Uusia imidatsolijohdannaisia
PCT/FI2001/000030 WO2001051472A1 (en) 2000-01-14 2001-01-12 New imidazole derivatives

Publications (2)

Publication Number Publication Date
PL356884A1 true PL356884A1 (pl) 2004-07-12
PL207281B1 PL207281B1 (pl) 2010-11-30

Family

ID=8557065

Family Applications (1)

Application Number Title Priority Date Filing Date
PL356884A PL207281B1 (pl) 2000-01-14 2001-01-12 Pochodna imidazolu, kompozycja ją zawierająca, jej zastosowanie i sposób wytwarzania

Country Status (30)

Country Link
EP (1) EP1261588B1 (pl)
JP (1) JP2003519688A (pl)
KR (1) KR20020084091A (pl)
CN (1) CN1187336C (pl)
AR (1) AR029432A1 (pl)
AT (1) ATE280161T1 (pl)
AU (1) AU769896B2 (pl)
BR (1) BR0107644A (pl)
CA (1) CA2397283A1 (pl)
CZ (1) CZ20022358A3 (pl)
DE (1) DE60106572T2 (pl)
DK (1) DK1261588T3 (pl)
EE (1) EE200200389A (pl)
ES (1) ES2228884T3 (pl)
FI (1) FI20000073A0 (pl)
GC (1) GC0000218A (pl)
HK (1) HK1049999B (pl)
HU (1) HUP0301008A3 (pl)
IL (1) IL150506A0 (pl)
MX (1) MXPA02006872A (pl)
NO (1) NO323117B1 (pl)
NZ (1) NZ519919A (pl)
PE (1) PE20011230A1 (pl)
PL (1) PL207281B1 (pl)
PT (1) PT1261588E (pl)
RU (1) RU2265598C2 (pl)
SI (1) SI1261588T1 (pl)
SK (1) SK286320B6 (pl)
WO (1) WO2001051472A1 (pl)
ZA (1) ZA200205301B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20002756A0 (fi) * 2000-12-15 2000-12-15 Orion Yhtymae Oyj Uusi hoitomenetelmä
TW200306783A (en) 2002-04-29 2003-12-01 Fmc Corp Pesticidal heterocycles
FI20022159A0 (fi) * 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä
DE102004035322A1 (de) * 2004-07-21 2006-02-16 Universität des Saarlandes Selektive Hemmstoffe humaner Corticoidsynthasen
RU2009112496A (ru) 2006-10-19 2010-11-27 Ф. Хоффманн-Ля Рош Аг (Ch) Аминометил-4-имидазолы
JP2010510184A (ja) * 2006-11-16 2010-04-02 エフ．ホフマン−ラ ロシュ アーゲー 置換４−イミダゾール類
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
AR090557A1 (es) * 2012-04-02 2014-11-19 Orion Corp DERIVADOS IMIDAZOLICOS AGONISTAS ADRENERGICOS a2

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB2244431A (en) * 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
US5541211A (en) * 1991-06-18 1996-07-30 Orion-Yhtyma Oy Administration of atipamezole to elicit a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic transmission
GB9113077D0 (en) * 1991-06-18 1991-08-07 Orion Yhtymae Oy Use of atipamezole
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
PL341009A1 (en) * 1997-12-04 2001-03-12 Allergan Sales Substitute derivatives of imidazole exhibiting agonist-like activity in respect to adrenergic alpha 2b or 2b/2c receptors
US6503935B1 (en) * 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
TWI283669B (en) * 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors

Also Published As

Publication number Publication date
HUP0301008A2 (hu) 2003-10-28
PL207281B1 (pl) 2010-11-30
AR029432A1 (es) 2003-06-25
HK1049999B (zh) 2005-05-13
WO2001051472A1 (en) 2001-07-19
SK9982002A3 (en) 2003-03-04
RU2002121777A (ru) 2004-01-10
HK1049999A1 (en) 2003-06-06
ES2228884T3 (es) 2005-04-16
EE200200389A (et) 2003-10-15
SK286320B6 (en) 2008-07-07
NO323117B1 (no) 2007-01-08
BR0107644A (pt) 2002-10-08
CZ20022358A3 (cs) 2007-12-19
DK1261588T3 (da) 2005-02-14
DE60106572T2 (de) 2006-02-09
EP1261588A1 (en) 2002-12-04
IL150506A0 (en) 2003-02-12
PT1261588E (pt) 2005-02-28
KR20020084091A (ko) 2002-11-04
PE20011230A1 (es) 2001-12-08
CA2397283A1 (en) 2001-07-19
DE60106572D1 (de) 2004-11-25
RU2265598C2 (ru) 2005-12-10
SI1261588T1 (en) 2005-02-28
HUP0301008A3 (en) 2004-01-28
JP2003519688A (ja) 2003-06-24
ZA200205301B (en) 2003-10-02
MXPA02006872A (es) 2003-01-28
NO20023298D0 (no) 2002-07-08
ATE280161T1 (de) 2004-11-15
WO2001051472A9 (en) 2003-01-23
CN1187336C (zh) 2005-02-02
NZ519919A (en) 2003-10-31
AU769896B2 (en) 2004-02-05
NO20023298L (no) 2002-09-06
AU2853201A (en) 2001-07-24
EP1261588B1 (en) 2004-10-20
FI20000073A0 (fi) 2000-01-14
CN1395567A (zh) 2003-02-05
GC0000218A (en) 2006-03-29

Similar Documents

Publication Publication Date Title
AU2002211216A1 (en) Substituted aminopropoxyaryl derivatives useful as agonists for lxr
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
MX9800804A (es) Derivados de pirrolidina que tienen actividad inhibitoria de la fosfolipasa a2.
WO2001019828A3 (en) Kinase inhibitors as therapeutic agents
IL142649A0 (en) Azole derivatives
DE69831868D1 (en) Antithrombosemittel
IL161074A0 (en) Lactam derivatives as antagonists for human 11cby receptors
WO2001017972A3 (de) Neue herbizide
AU2003229953A1 (en) Phthalazinone derivatives
TW200510440A (en) Novel compounds
AU2002246728A1 (en) Carboline derivatives
BG106340A (en) Substituted oxoazaheterocyclyl compounds
TR200403436T2 (tr) Kristalin 1-metilkarbapenem türevleri.
BG104447A (en) Biphenylamidine derivatives
WO2001036425A3 (de) Imidazolverbindungen als phosphodiesterase vii-hemmer
GC0000218A (en) New imidazole derivatives
AU2003223340A1 (en) Certain pharmaceutically useful substituted aminoalkyl heterocycles
MXPA04004802A (es) Derivados del 1,2,4-triazol que contienen un grupo sulfamato como inhibidores de aromatasa.
AU4424401A (en) Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
AU2001296699A1 (en) Condensed pyrazindione derivatives as pde inhibitors
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
EP1026162A4 (en) ANTI-RHUMATISMAL AGENT
FI952420A0 (fi) Glukopyranosidibentsotiofeenit
AU2002356319A1 (en) Dna minor groove binding compounds
AU2002214320A1 (en) Imidazole derivatives, process for their preparation and their use

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20110112